Final - June 16, 2017

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

page 1 of 2

PURPOSE PRESIDER/PRESENTER(s)

Dr. Nancy Bennett (ACIP Chair)

Dr. Amanda Cohn (ACIP Executive Secretary; CDC)

9:00 Hepatitis Vaccines 

Introduction

Hepatitis A vaccine background

Cost-effectiveness analysis of catch-up hepatitis A vaccination 

among unvaccinated/partially-vaccinated children

Updated ACIP routine recommendations for use of hepatitis A 

vaccine

Updated ACIP recommendations for use of hepatitis A vaccine 

and immune globulin for post-exposure prophylaxis and for 

international travelers

Dr. Arthur Reingold (ACIP, WG Chair)

Dr. Noele Nelson (CDC/NCHHSTP)

Dr. David Rein (NORC, University of Chicago)

Dr. Noele Nelson (CDC/NCHHSTP)

Dr. Ruth Link-Gelles (CDC/NCHHSTP)

10:30

10:45 Influenza 

Introduction

Influenza surveillance update

Vaccine effectiveness update

Vaccine safety update

Flublok in pregnancy

Public comment

Proposed recommendations 

Dr. Emmanuel (Chip) Walter (ACIP, WG Chair)

Ms. Alicia Budd (CDC/NCIRD)

Dr. Jill Ferdinands (CDC/NCIRD)

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. Wayne Hachey (Protein Sciences)

Dr. Lisa Grohskopf (CDC/NCIRD)

12:30

1:45 Herpes Zoster Vaccine

Introduction

Zostavax Phase IV study

Zostavax GRADE

Herpes Zoster vaccine revaccination data

Dr. Ed Belongia (ACIP, WG Chair)

Dr. Nicola Klein (Kaiser Permanente Northern 

California)

Ms. Angela Guo (CDC/NCIRD)

Dr. Romulo Colindres (GSK)

3:00

3:30 Cost effectiveness models

Considerations for the use of herpes zoster vaccines 

Dr. Andrew Leidner (CDC/NCIRD)

Dr. Kathleen Dooling (CDC/NCIRD)

4:15 Varicella 

Impact of the U.S. varicella vaccination program on the 

epidemiology of herpes zoster

Information 

& Discussion

Dr. Rafael Harpaz (CDC/NCIRD)

4:45 Anthrax Vaccine Workgroup

Introduction

Anthrax vaccine workgroup information

Dr. David Stephens (ACIP, WG Chair)

Dr. Kate Hendricks (CDC/NCEZID)

5:05 Vaccine Supply Information Dr. Jeanne Santoli (CDC/NCIRD)

5:20 Public Comment

5:35 Adjourn

Information

Wednesday, June 21

8:30 Welcome & Introductions

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center, Kent "Oz" Nelson Auditorium

Atlanta, Georgia 30329 

June 21-22, 2017

AGENDA ITEM

Information 

& Discussion

Break

Information 

& Discussion 

Information 

& Discussion

Lunch

Information 

& Discussion

Vote

Break
Final - June 16, 2017

page 2 of 2

Thursday, June 22

8:00 Agency Updates & Unfinished Business

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NIH, NVPO Information Dr. Nancy Messonnier (CDC/NCIRD); Ex Officio 

Members

8:15 Dengue Virus Vaccines

Introduction

Dengue epidemiology in United States and U.S. territories

Dr. Chip Walter (ACIP, WG Chair)

Dr. Steve Waterman (CDC/NCEZID)

8:45 Yellow Fever Vaccine

Introduction

Update on implementation of IND protocol and yellow fever 

vaccine distribution

Review of protocol inclusion criteria and current ACIP 

recommendations

Dr. Chip Walter (ACIP, WG Chair)

Dr. David Greenberg (Sanofi Pasteur)

Dr. Erin Staples (CDC/NCEZID)

9:15

9:45 Mumps Disease and Vaccine

Introduction 

Update on mumps epidemiology in the United States, 2017 and 

review of published studies of 3rd dose MMR for mumps 

outbreak control

Effectiveness of a third MMR dose during a mumps outbreak in 

a highly vaccinated university population, 2015-2016

Dr. Kelly Moore (ACIP, WG Chair)

Dr. Mona Marin (CDC/NCIRD)

Dr. Cristina Cardemil (CDC/NCIRD)

10:45 Meningococcal 

Introduction

Meningococcal disease and vaccine response in patients 

receiving Eculizumab

Dr. David Stephens (ACIP, WG Chair)

Dr. Lucy McNamara (CDC/NCIRD)

11:30 Vaccine Adverse Event Reporting System (VAERS) 

Vaccine safety: transition to the new VAERS 2.0 reporting form Information Dr. Tom Shimabukuro (CDC/NCEZID)

11:35 Evidence Based Recommendations Information Dr. Arthur Reingold (ACIP, WG Chair)

11:40 Public Comment

11:50 Adjourn

Acronyms

CDC

CMS

DoD

DVA

FDA

GRADE

HRSA

IHS

NCHHSTP

NCIRD

NCEZID

NIH

NVPO

VFC

WG

Information 

& Discussion

Information 

& Discussion

Information 

& Discussion

Break

Indian Health Service

National Institutes of Health

National Vaccine Program Office

National Center for Emerging and Zoonotic Diseases [of CDC/OID]

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

Centers for Medicare and Medicaid Services 

Centers for Disease Control & Prevention

Food and Drug Administration

Department of Veterans Affairs

Department of Defense

Grading of Recommendations Assessment, Development and Evaluation

Work Group

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

Vaccines for Children

Health Resources and Services Administration

Information 

& Discussion